Publications by authors named "Maria Dahl Mjaavatten"
Objective: To assess the 2-year effect on disease activity and health-related quality of life (HRQoL) of implementing a clinical practice treat-to-target (T2T) strategy in patients with rheumatoid arthritis (RA).
Methods: Patients in the Norwegian Very Early Arthritis Cohort 2.0 (NOR-VEAC 2.
Article Synopsis
- The study aimed to assess the types of inflammatory arthritis (IA) diagnosed in patients with symptoms lasting less than 16 weeks and their outcomes after two years.
- Data from a Norwegian clinic involving 1,017 patients showed that common diagnoses included undifferentiated arthritis and rheumatoid arthritis, with 59% of patients experiencing resolution of their arthritis without needing disease-modifying treatments.
- After two years, significant improvements were observed in pain, fatigue, and overall health-related quality of life among those followed, indicating positive clinical outcomes regardless of the initial diagnosis.
Objective: The present study was undertaken to investigate the joint distribution and 2-year outcome of patients with recent-onset monoarthritis.
Methods: Adult patients with clinically apparent monoarthritis of ≤16 weeks' duration were included in a multicenter 2-year longitudinal study. Clinical characteristics, joint distribution, development of chronic inflammatory rheumatic disease (CIRD), as well as classification criteria according to the American College of Rheumatology (ACR)/European League Against Rheumatism (EULAR) 2010 criteria for RA were studied.
Objective: To develop a multimorbidity index (MMI) based on health-related quality of life (HRQol).
Methods: The index was developed in an observational RA cohort. In all, 40 morbidities recommended as core were identified using ICD-9 codes.
Objective: To investigate the distribution of joint involvement in a cohort of patients with very recent onset arthritis and describe the disease characteristics in these patients.
Methods: A very early arthritis clinic (NOR-VEAC) was established as a multicenter study. General practitioners were asked to refer patients presenting with at least 1 swollen joint of maximum 16 weeks' duration.